RECRUITING

Cervical and Endometrial Cancer Screening in Patients Seeking Gender-Affirming Hysterectomy

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study aims to quantify the rates of cervical cancer screening and endometrial sampling prior to gender-affirming hysterectomy, assess the need for these tests in TGD individuals, and explore patient-centered options for these tests. By assessing the status of testing and correlation with hysterectomy pathology, this study will provide preliminary data on the current state of guideline-concordant care and provide initial evidence for the development of evidence-based guidelines in the future

Official Title

Cervical and Endometrial Cancer Screening in Patients Seeking Gender-Affirming Hysterectomy

Quick Facts

Study Start:2025-06-30
Study Completion:2027-06-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT07075731

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Not specified
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * 18 years and older
  2. * Able to provide voluntary written consent prior to the performance of any research related activity. Patients who can provide informed consent
  3. * Able to understand, speak, read, and write in English
  4. * Patients who have undergone hysterectomy, or plan to have a hysterectomy
  5. * Patients who are transgender and gender diverse"
  1. * Opted out of research
  2. * \<18 years old
  3. * Lacks capacity to consent/has diminished capacity to consent
  4. * Cannot provide informed consent
  5. * Those on the study's community advisory board

Contacts and Locations

Study Contact

Maria Bunch
CONTACT
612-624-2018
obgynresearch@umn.edu

Principal Investigator

Meredith Wise
PRINCIPAL_INVESTIGATOR
University of Minnesota

Study Locations (Sites)

University of Minnesota
Minnesota, Minnesota, 55455
United States

Collaborators and Investigators

Sponsor: University of Minnesota

  • Meredith Wise, PRINCIPAL_INVESTIGATOR, University of Minnesota

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-06-30
Study Completion Date2027-06-30

Study Record Updates

Study Start Date2025-06-30
Study Completion Date2027-06-30

Terms related to this study

Additional Relevant MeSH Terms

  • Cancer Screening
  • Transgender
  • Gender Diverse Populations